Member

However, it is currently a legal commitment that we can undertake that type of research. It is backed up by legal, heavy regulation. Until that is achieved, the immediate and critical issue remains that the sector is being targeted by protesters who oppose current clinical research methods. Disruption to the industry risks weakening the country’s ability to act in a medical crisis. If protest activity continues to interfere with essential research, it will seriously undermine the UK’s readiness for the next pandemic. That is why today the Government are taking the proportionate step to reduce supply-chain interference, to protect the sector’s ability to operate in the UK, to support the UK’s pandemic preparedness and national health resilience, and to allow this sector to operate while our strategy is put in place.